NDI Notification Guidance Deadline Included In Senate Draft Bill For FDA User Fee Programs

HELP Committee Chairwoman Patty Murray, and ranking member Richard Burr also include supplement registration requirement in discussion draft for reauthorizing FDA’s user fee programs for prescription, generic and biosimilar drugs and medical devices.

• Source: Shutterstock

US dietary supplement industry stakeholders are split on the Food and Drug Administration requiring product registration as a draft Senate bill would authorize, but agreement is likely on a provision ordering the agency to publish a final guidance on new dietary ingredient notifications.

Health, Education, Labor and Pensions Committee Chairwoman Patty Murray, D-WA, and ranking member Richard Burr, R-NC, included the supplement registration and NDI notification guidance provisions in a

Murray and Burr’s draft follows the April introduction of a bill, S. 4090, authored by Sens. Dick Durbin, D-IL, and Mike Braun, R-IN, more narrowly focused on requiring registration with the FDA of all vitamin, mineral and supplement products available for sale in the US. The product registration language in the discussion draft largely tracks with the language in S. 4090, which was assigned to the HELP Committee

More from Regulation

More from Policy & Regulation